Fennec Pharmaceuticals
FENC | NASDAQ
$12.76
+$1.14 (+9.81%)
At close: Nov 16, 2026, 4:00 PM ET
$12.70
-$0.06 (-0.47%)
After-hours:
Nov 16, 2026, 7:30 PM ET
Fennec Pharmaceuticals Company Profile
Company profile explainedCompany Profile
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
Key Executives
| Name | Position |
|---|---|
| Jeffrey S. Hackman | Chief Executive Officer & Director |
| Robert C. Andrade | Chief Financial Officer |
| Christiana Cioffi | Chief Strategy Officer |
| Lei Fang | President of Pharstat Inc |
| Mark Gowland | Controller |
| Pierre S. Sayad | Chief Medical Officer |
| Terry Evans | Chief Commercial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 19, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Oct 13, 2026 | 4 | Filing |
| Oct 13, 2026 | 4 | Filing |
| Oct 13, 2026 | 4 | Filing |
| Oct 13, 2026 | 4 | Filing |
| Oct 13, 2026 | 4 | Filing |
| Oct 01, 2026 | 4 | Filing |
| Oct 01, 2026 | 4 | Filing |
| Oct 01, 2026 | 4 | Filing |
| Oct 01, 2026 | 4 | Filing |
Fennec Pharmaceuticals
| Country | United States |
| IPO Date | Sep 15, 2017 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 35 |
| CEO | Jeffrey S. Hackman |
Contact Details
68 TW Alexander Drive Research Triangle Park,
North Carolina 27709 United States
Stock Details
| Ticker Symbol | FENC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001211583 |
| CUSIP Number | 31447P100 |
| ISIN Number | CA31447P1009 |
| SIC Code | 2836 |
Add to Watchlist
Select watchlists to add or remove FENC